Investigating the antitumor effects of a novel ruthenium (II) complex on malignant melanoma cells: An NMR-based metabolomic approach

This publication has 35 references indexed in Scilit:

• Potential Markers of Cisplatin Treatment Response Unveiled by NMR Metabolomics of Human Lung Cells
  Molecular Pharmaceutics, 2013
• Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
  Nature, 2011
• Glutathione in Cancer Cell Death
  Cancers, 2011
• Metabolic Pathway Alterations that Support Cell Proliferation
  Cold Spring Harbor Symposia on Quantitative Biology, 2011
• Nuclear Magnetic Resonance (NMR) Study of the Effect of Cisplatin on the Metabolic Profile of MG-63 Osteosarcoma Cells
  Journal of Proteome Research, 2010
• The status of platinum anticancer drugs in the clinic and in clinical trials
  Dalton Transactions, 2010
• Metabonomics Techniques and Applications to Pharmaceutical Research & Development
  Pharmaceutical Research, 2006
• From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
  Journal of Inorganic Biochemistry, 2006
• A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells
  Cell Death & Differentiation, 2004
• Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line
  Cell Death & Differentiation, 2002